Invesco S&P 500 Equal Weight Health Care ETF (RSPH)

The Invesco S&P 500 Equal Weight Health Care ETF is currently exhibiting a distinct short-term bullish bias driven by strong relative strength, despite a recent annual dip. Over the last two weeks, the price surged from roughly $35.20 to $37.77, outperforming its 50-day and 200-day moving averages significantly. This momentum suggests the market is re-rating the healthcare sector, likely anticipating the continued impact of GLP-1 drugs and other innovations that favor smaller-cap constituents within the equal-weight structure. While the trailing twelve-month return was negative (-5.5%), the broader nine-year trajectory remains robust (+86%), indicating the recent pullback was a correction rather than a structural breakdown. The valuation is elevated at a P/E of 26.5x, which is typical for a sector-leading ETF but warrants caution if growth slows. The dividend yield of 0.67% is modest and insufficient for income-focused investors, serving primarily as a return enhancer for growth seekers. The lack of options activity suggests the crowd is waiting for confirmation before committing capital, but the recent price action provides a strong catalyst for a near-term continuation.